Insider · CIK 0001631836
Holt Matthew S.
Reports to the SEC for 4 companies · NEW YORK, NY
Transactions
11
Companies
4
Filings
9
CIK
0001631836
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-03-29 | Signify Health, Inc.D Disposition to Issuer | — |
| 2022-05-19 | Signify Health, Inc.A Award | — |
| 2022-05-12 | AVTRAvantor, Inc.A Award | — |
| 2022-04-01 | AVTRAvantor, Inc.A Award | — |
| 2022-02-16 | Signify Health, Inc.J Other | — |
| 2021-02-16 | Signify Health, Inc.A Award | — |
| 2016-06-17 | Bellerophon Therapeutics, Inc.Stock Option (right to buy)A Award | — |
| 2016-04-28 | Bellerophon Therapeutics, Inc.A Award | — |
| 2015-02-19 | Bellerophon Therapeutics, Inc.P Purchase | +$12.8M |
| 2015-02-12 | Bellerophon Therapeutics, Inc.D Disposition to Issuer | — |
| 2015-02-12 | Bellerophon Therapeutics, Inc.A Award | — |
Recent filings
- 4Holt Matthew S.0000899243-23-009919SEC(opens sec.gov)
- 4Holt Matthew S.0000950103-22-009035SEC(opens sec.gov)
- 4Holt Matthew S.0001722482-22-000129SEC(opens sec.gov)
- 4Holt Matthew S.0001722482-22-000090SEC(opens sec.gov)
- 4Holt Matthew S.0000950103-22-002873SEC(opens sec.gov)
- 4Holt Matthew S.0000950103-21-002443SEC(opens sec.gov)
- 4Bellerophon Therapeutics, Inc.0001600132-16-000089SEC(opens sec.gov)
- 4Bellerophon Therapeutics, Inc.0001600132-16-000045SEC(opens sec.gov)
- 4Bellerophon Therapeutics, Inc.0001104659-15-013148SEC(opens sec.gov)
Companies
Address
C/O NEW MOUNTAIN CAPITAL, L.L.C. 787 SEVENTH AVENUE, 49TH FLOOR
NEW YORK, NY, 10019